You are here: All Products  > Usynova Out-Licenses KRASG12D Inhibitor to AstraZeneca in $419 Million Agreement

Usynova Out-Licenses KRASG12D Inhibitor to AstraZeneca in $419 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products